Therapeutic Area Director
+6 year(s) experience
Hardik’s interest in oncology stems from the cutting-edge drug development caused by the critical need for more effective treatments. He aims to provide clients with the tools that will assist them in making greater contributions to the advancement of oncology treatments.
Since joining Datamonitor Healthcare in 2013, Hardik has contributed content and insights on diseases within the oncology, respiratory, and immunology and inflammation therapeutic areas.
He holds a BSc in Biomedical Engineering and a Masters in Engineering and Management, both from Case Western Reserve University.
Immunotherapies are one of the fastest growing treatment algorithms in pharma at the moment, and non-small cell lung cancer (NSCLC) is just one area of oncology that is going to make the transition into being dominated by this type of therapy.
Download your free infographic using the adjacent form. Get to grips with early-phase opportunities in our non-small cell lung cancer (NSCLC) pipeline with our latest infographic.